Join Prof. Hellings and Prof. Corso in dicussion on the factors affecting complete control of CRSwNP, including treatment types, comorbidities, and the need for more data on biologics.
Learn about the variability in achieving control of CRSwNP across different medical centers and patient profiles. Factors such as the presence of comorbid asthma or aspirin intolerance can affect the success rate of treatments like sinus surgery and biologics. The need for more data on long-term outcomes and the role of Japan's JESREC score in evaluating patient responses are highlighted.
Professor and Clinic Head of the Department of Otorhinolaryngology | University Hospitals of Leuven, Belgium
See author’s profile